Stock Taper
Heart Test Laboratories, Inc. develops cardiovascular diagnostic devices like the MyoVista wavECG for clinics, urgent care, and hospitals, providing advanced ECG solutions since 2007 in Southlake, Texas.

The MyoVista® wavECG™ is an AI-powered 12-lead ECG device that detects subtle cardiac dysfunctions like diastolic issues, supporting early heart disease diagnosis through its cloud platform.
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
MOVE | $14.40 | COMPARE |
NDRA | $6.17 | COMPARE |
GCTK | $3.02 | COMPARE |
SHPH | $3.46 | COMPARE |
BBLG | $0.57 | COMPARE |
BJDX | $0.83 | COMPARE |